Skip to main content

Panel Backs Approval of Atrial Fibrillation Drug : Dronedarone reduced cardiac hospitalizations, but not mortality, in a multinational trial.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Panel Backs Approval of Atrial Fibrillation Drug : Dronedarone reduced cardiac hospitalizations, but not mortality, in a multinational trial.

User login

Username

Password

Reset your password

Type	Lead	score